LOCUS       QTZ43201                1231 aa            linear   VRL 20-APR-2021
DEFINITION  surface glycoprotein, partial [Severe acute respiratory syndrome
            coronavirus 2].
ACCESSION   QTZ43201
VERSION     QTZ43201.1
DBSOURCE    accession MW973536.1
KEYWORDS    .
SOURCE      Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  ORGANISM  Severe acute respiratory syndrome coronavirus 2
            Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
            Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
            Betacoronavirus; Sarbecovirus; Betacoronavirus pandemicum.
REFERENCE   1  (residues 1 to 1231)
  AUTHORS   Deng,X., Garcia-Knight,M.A., Khalid,M.M., Servellita,V., Wang,C.,
            Morris,M.K., Sotomayor-Gonzalez,A., Glasner,D.R., Reyes,K.R.,
            Gliwa,A.S., Reddy,N.P., Sanchez San Martin,C., Federman,S.,
            Cheng,J., Balcerek,J., Taylor,J., Streithorst,J.A., Miller,S.,
            Kumar,G.R., Sreekumar,B., Chen,P.Y., Schulze-Gahmen,U., Taha,T.Y.,
            Hayashi,J., Simoneau,C.R., McMahon,S., Lidsky,P.V., Xiao,Y.,
            Hemarajata,P., Green,N.M., Espinosa,A., Kath,C., Haw,M., Bell,J.,
            Hacker,J.K., Hanson,C., Wadford,D.A., Anaya,C., Ferguson,D.,
            Lareau,L.F., Frankino,P.A., Shivram,H., Wyman,S.K., Ott,M.,
            Andino,R. and Chiu,C.Y.
  TITLE     Transmission, infectivity, and antibody neutralization of an
            emerging SARS-CoV-2 variant in California carrying a L452R spike
            protein mutation
  JOURNAL   medRxiv (2021)
   PUBMED   33758899
  REMARK    Publication Status: Online-Only
REFERENCE   2  (residues 1 to 1231)
  AUTHORS   Chiu,C.Y., Deng,X., Wang,C., Servellita,V., Sotomayor-Gonzalez,A.,
            Wyman,S.K., Anaya,C., IDLB COVIDNet,C.D.P.H. and COVID Tracker
            Consortium,C.Z.B.
  TITLE     Direct Submission
  JOURNAL   Submitted (19-APR-2021) Laboratory Medicine, University of
            California, San Francisco, 185 Berry Street, Box 0134, San
            Francisco, CA 94107, USA
COMMENT     Method: conceptual translation.
FEATURES             Location/Qualifiers
     source          1..1231
                     /organism="Severe acute respiratory syndrome coronavirus
                     2"
                     /isolate="SARS-CoV-2/human/USA/CA-UCSF-UC876/2020"
                     /isolation_source="nasopharyngeal swab"
                     /host="Homo sapiens"
                     /db_xref="taxon:2697049"
                     /geo_loc_name="USA"
                     /collection_date="2020-12-27"
     Protein         <1..1231
                     /product="surface glycoprotein"
     Region          1..208
                     /region_name="CoV_Spike_S1_NTD"
                     /note="N-terminal domain of the S1 subunit of coronavirus
                     Spike (S) proteins; cl40465"
                     /db_xref="CDD:477362"
     Region          281..499
                     /region_name="CoV_Spike_S1_RBD"
                     /note="receptor-binding domain of the S1 subunit of
                     coronavirus spike (S) proteins; cl40478"
                     /db_xref="CDD:424109"
     Site            order(313,332..335,339..342,344,348,354,363..364,366,
                     372..373,375,382,385,472,474..475,477)
                     /site_type="other"
                     /note="trimer interface [polypeptide binding]"
                     /db_xref="CDD:394823"
     Site            order(364,367,375,407,411,413..414,447,449,451)
                     /site_type="other"
                     /note="putative receptor binding site [polypeptide
                     binding]"
                     /db_xref="CDD:394823"
     Site            order(396,405..414,447..453,465..466)
                     /site_type="other"
                     /note="receptor binding motif"
                     /db_xref="CDD:394823"
     Region          501..1166
                     /region_name="SARS-CoV-like_Spike_SD1-2_S1-S2_S2"
                     /note="SD-1 and SD-2 subdomains, the S1/S2 cleavage
                     region, and the S2 fusion subunit of the spike (S)
                     glycoprotein from SARS-CoV-2 (COVID-19) and related
                     betacoronaviruses in the B lineage; cd22378"
                     /db_xref="CDD:411965"
     Site            order(561,574,615,667,675,759,1032,1056,1092,1116,1131,
                     1152)
                     /site_type="other"
                     /note="N-linked glycosylation sites [posttranslational
                     modification]"
                     /db_xref="CDD:411965"
     Site            order(630..634,636,641..646,648..667)
                     /site_type="other"
                     /note="S1/S2 cleavage region"
                     /db_xref="CDD:411965"
     Site            746..764
                     /site_type="other"
                     /note="fusion peptide"
                     /db_xref="CDD:411965"
     Site            774..791
                     /site_type="other"
                     /note="internal fusion peptide"
                     /db_xref="CDD:411965"
     Region          876..941
                     /region_name="heptad repeat 1"
                     /note="heptad repeat 1 [structural motif]"
                     /db_xref="CDD:411965"
     Region          1120..1161
                     /region_name="heptad repeat 2"
                     /note="heptad repeat 2 [structural motif]"
                     /db_xref="CDD:411965"
     CDS             1..1231
                     /gene="S"
                     /coded_by="MW973536.1:<21652..25348"
                     /codon_start=2
ORIGIN      
        1 frssvlhstq dlflpffsnv twfhaihvsg tngtkrfdnp vlpxxxxxxx xxxxxxxxxx
       61 xxxxxxxxxs ktqsllivnn atnvvikvce fqfcndpflg vyyhknnksw mesefrvyss
      121 annctfeyvs qpflmdlegx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xrdlpqgfsa
      181 leplvdlpig initrfqtll alhrsyltpg xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx
      241 xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx tesivrfpni tnlcpfgevf
      301 natrfasvya wnrkrisncv adysvlynsa sfstfkcygv sptklndlcf tnvyadsfvi
      361 rgdevrqiap gqtgkiadyn yklpddftgc viawnsnnld skvggnynyl yrlfrksnxx
      421 xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxg vgyqpyrvvv lsfellhapa
      481 tvcgpkkstn lvknkcvnfn fngltgtgvl tesnkkflpf qqfgrdiadt tdavrdpqtl
      541 eilditpcsf ggvsvitpgt ntsnqvavly qgvnctevpv aihadqltpt wrvystgsnv
      601 fqtragclig aehvnnsyec dipigagica syqtqtnspr rarsvasqsi iaytmslgae
      661 nsvaysnnsi aiptnftisv tteilpvsmt ktsvdctmyi cgdstecsnl llqygsfctq
      721 lnraltgiav eqdkntqevf aqvkqiyktp pikdfggfnf sqilpdpskp skrsfiedll
      781 fnkvtladag fikqygdclg diaardlica qkfngltvlp plltdemiaq ytsallagti
      841 tsgwtfgaga alqipfamqm ayrfngigvt qnvlyenqkl ianqfnsaig kiqdslssta
      901 salgklqdvv nqnaqalntl vkqlssnfga issvlndils rldkveaevq idrlitgrlq
      961 slqtyvtqql iraaeirasa nlaatkmsec vlgqskrvdf cgkgyhlmsf pqsaphgvvf
     1021 lhvtyvpaqe knfttapaic hdgkahfpre gvfvsngthw fvtqrnfyep qiittdntfv
     1081 sgncdvvigi vnntvydplq peldsfkeel dkyfknhtsp dvdlgdisgi nasvvniqke
     1141 idrlnevakn lneslidlqe lgkyeqyikw pwyiwlgfia gliaivmvti mlccmtsccs
     1201 clkgccscgs cckfdeddse pvlkgvklhy t
//

